The coiled coil motif in polymer drug delivery systems

Biotechnology Advances

Volumn 31, Issue 1, 2013, Pages 90-96

  Pechar, Michal ^a   Pola, Robert ^a  

^a INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

Author keywords

Coiled coil; Drug delivery; Drug targeting; Hydrophilic polymer; Recombinant protein

Indexed keywords

BIOMEDICAL APPLICATIONS; COIL SYSTEMS; COILED COIL; COILED COIL PEPTIDE; DRUG-TARGETING; HYBRID POLYMERS; HYDROPHILIC POLYMERS; MACROMOLECULAR SYSTEMS; POLYMER DRUGS; STRUCTURAL PROTEINS;

DRUG DELIVERY; MEDICAL APPLICATIONS; OLIGOMERIZATION; OLIGOMERS; RECOMBINANT PROTEINS;

FUNCTIONAL POLYMERS;

RECOMBINANT PROTEIN;

BIOTECHNOLOGY; CHEMICAL PROPERTY; DRUG; DRUG DEVELOPMENT; MEDICINE; MOLECULAR ANALYSIS; POLYMER; PROTEIN;

CHEMICAL STRUCTURE; DRUG DELIVERY SYSTEM; GENETICS; HYDROGEL; METHODOLOGY; PROTEIN CONFORMATION; PROTEIN MOTIF; REVIEW; SOLUBILITY;

AMINO ACID MOTIFS; DRUG DELIVERY SYSTEMS; HYDROGELS; MODELS, MOLECULAR; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SOLUBILITY;

EID: 84871932362     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2012.01.003     Document Type: Review

References (54)

1. Apostolovic B., Klok H.A. pH-sensitivity of the E3/K3 heterodimeric coiled coil. Biomacromolecules 2008, 9:3173-3180.
2. Apostolovic B., Klok H.A. Copolymerization behavior of N-(2-hydroxypropyl)methacrylamide and a methacrylated coiled-coil peptide derivative. Biomacromolecules 2010, 11:1891-1895.
3. Apostolovic B., Danial M., Klok H.A. Coiled coils: attractive protein folding motifs for the fabrication of self-assembled, responsive and bioactive materials. Chem Soc Rev 2010, 39:3541-3575.
4. Apostolovic B., Deacon S.P.E., Duncan R., Klok H.A. Hybrid polymer therapeutics incorporating bioresponsive, coiled coil peptide linkers. Biomacromolecules 2010, 11:1187-1195.
5. Apostolovic B., Deacon S.P.E., Duncan R., Klok H.A. Cell uptake and trafficking behavior of non-covalent, coiled-coil based polymer-drug conjugates. Macromol Rapid Comm 2011, 32:11-18.
6. Brown O.J., Lopez S.A., Fuller A.O., Goodson T. Formation and reversible dissociation of coiled coil of peptide to the C-terminus of the HSVB5 protein: a time-resolved spectroscopic analysis. Biophys J 2007, 93:1068-1078.
7. Chao H.M., Houston M.E., Grothe S., Kay C.M., OConnorMcCourt M., Irvin R.T., Hodges R.S. Kinetic study on the formation of a de novo designed heterodimeric coiled-coil: use of surface plasmon resonance to monitor the association and dissociation of polypeptide chains. Biochemistry 1996, 35:12175-12185.
8. Chao H.M., Bautista D.L., Litowski J., Irvin R.T., Hodges R.S. Use of a heterodimeric coiled-coil system for biosensor application and affinity purification. J Chromatogr B 1998, 715:307-329.
9. De Crescenzo G., Litowski J.R., Hodges R.S., O'Connor-McCourt M.D. Real-time monitoring of the interactions of two-stranded de novo designed coiled-coils: effect of chain length on the kinetic and thermodynamic constants of binding. Biochemistry 2003, 42:1754-1763.
10. Deacon S.P.E., Apostolovic B., Carbajo R.J., Schott A.K., Beck K., Vicent M.J., Pineda-Lucena A., Klok H.A., Duncan R. Polymer coiled-coil conjugates: potential for development as a new class of therapeutic "molecular switch". Biomacromolecules 2011, 12:19-27.
11. Etrych T., Strohalm J., Kovar L., Kabesova M., Rihova B., Ulbrich K. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting, I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity. J Control Release 2009, 140:18-26.
12. Gonzalez L., Plecs J.J., Alber T. An engineered allosteric switch in leucine-zipper oligomerization. Nat Struct Biol 1996, 3:510-515.
13. Graddis T.J., Myszka D.G., Chaiken I.M. Controlled formation of model homodimer and heterodimer coiled-coil polypeptides. Biochemistry 1993, 32:12664-12671.
14. Griffiths P.C., Paul A., Apostolovic B., Klok H.A., de Luca E., King S.M., Heenan R.K. Conformational consequences of cooperative binding of a coiled-coil peptide motif to poly(N-(2-hydroxypropyl)methacrylamide) HPMA copolymers. J Control Release 2011, 153:173-179.
15. Harbury P.B., Zhang T., Kim P.S., Alber T. A switch between 2-stranded, 3-stranded and 4-stranded coiled coils in gcn4 leucine-zipper mutants. Science 1993, 262:1401-1407.
16. Hodges R.S. De novo design of alpha-helical proteins: basic research to medical applications. Biochem Cell Biol 1996, 74:133-154.
17. Hongrapipat J., Kopeckova P., Liu J., Prakongpan S., Kopecek J. Combination chemotherapy and photodynamic therapy with Fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells. Mol Pharmaceut 2008, 5:696-709.
18. Ishii Y., Yoshida T., Funatsu T., Wazawa T., Yanagida T. Fluorescence resonance energy transfer between single fluorophores attached to a coiled-coil protein in aqueous solution. Chem Phys 1999, 247:163-173.
19. Kashiwada A., Hiroaki H., Kohda D., Nango M., Tanaka T. Design of a heterotrimeric alpha-helical bundle by hydrophobic core engineering. J Am Chem Soc 2000, 122:212-215.
20. Kopecek J. Smart and genetically engineered biomaterials and drug delivery systems. Eur J Pharm Sci 2003, 20:1-16.
21. Kopecek J., Wang C., Stewart R. Tailor-made hybrid hydrogels: synthetic macromolecules crosslinked by coiled coil protein domains. Abstr Pap Am Chem Soc 1998, 216:U56-U57.
22. Kopecek J., Tang A.J., Wang C., Stewart R.J. De novo design of biomedical polymers: hybrids from synthetic macromolecules and genetically engineered protein domains. Macromol Symp 2001, 174:31-42.
23. Kovář M., Mrkvan T., Strohalm J., Etrych T., Ulbrich K., Štastný M., Říhová B. HPMA copolymer-bound doxorubicin targeted to tumor specific antigen of BCL1 mouse B cell leukemia. J Control Release 2003, 92:315-330.
24. Kral V., Mader P., Collard R., Fabry M., Horejsi M., Rezacova P., Kozisek M., Zavada J., Sedlacek J., Rulisek L., Brynda J. Stabilization of antibody structure upon association to a human carbonic anhydrase epitope studied by X-ray crystallography, microcalorimetry, and molecular dynamics simulations. Proteins 2008, 71:1275-1287.
25. Li Y., Wang H., Oosterwijk E., Selman Y., Mira J.C., Medrano T., Shiverick K.T., Frost S.C. Antibody-specific detection of CAIX in breast and prostate cancers. Biochem Biophys Res Commun 2009, 386:488-492.
26. Lindhout D.A., Litowski J.R., Mercier P., Hodges R.S., Sykes B.D. NMR solution structure of a highly stable de novo heterodimeric coiled-coil. Biopolymers 2004, 75:367-375.
27. Litowski J.R., Hodges R.S. Designing heterodimeric two-stranded alpha-helical coiled-coils: the effect of chain length on protein folding, stability and specificity. J Pept Res 2001, 58:477-492.
28. Litowski J.R., Hodges R.S. Designing heterodimeric two-stranded alpha-helical coiled-coils - effects of hydrophobicity and alpha-helical propensity on protein folding, stability, and specificity. J Biol Chem 2002, 277:37272-37279.
29. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000, 65:271-284.
30. Mason J.M., Arndt K.M. Coiled coil domains: stability, specificity, and biological implications. Chembiochem 2004, 5:170-176.
31. Moll J.R., Ruvinov S.B., Pastan I., Vinson C. Designed heterodimerizing leucine zippers with a range of pIs and stabilities up to 10(-15) M. Protein Sci 2001, 10:649-655.
32. Myszka D.G., Chaiken I.M. Design and characterization of an intramolecular antiparallel coiled-coil peptide. Biochemistry (Mosc) 1994, 33:2363-2372.
33. Pechar M., Kopeckova P., Joss L., Kopecek J. Associative diblock copolymers of poly(ethylene glycol) and coiled-coil peptides. Macromol Biosci 2002, 2:199-206.
34. Pechar M., Pola R., Laga R., Ulbrich K., Bednarova L., Malon P., Sieglova I., Kral V., Fabry M., Vanek O. Coiled coil peptides as universal linkers for the attachment of recombinant proteins to polymer therapeutics. Biomacromolecules 2011, 12:3645-3655.
35. Petka W.A., Harden J.L., McGrath K.P., Wirtz D., Tirrell D.A. Reversible hydrogels from self-assembling artificial proteins. Science 1998, 281:389-392.
36. Su J.Y., Hodges R.S., Kay C.M. Effect of chain-length on the formation and stability of synthetic alpha-helical coiled coils. Biochemistry 1994, 33:15501-15510.
37. Tang A.J., Kopecek J. Presentation of epitopes on genetically engineered peptides and selection of lymphoma-targeting moieties based on epitope biorecognition. Biomacromolecules 2002, 3:421-431.
38. Tang A.J., Wang C., Stewart R., Kopecek J. Self-assembled peptides exposing epitopes recognizable by human lymphoma cells. Bioconjug Chem 2000, 11:363-371.
39. Tang A., Wang C., Stewart R.J., Kopecek J. The coiled coils in the design of protein-based constructs: hybrid hydrogels and epitope displays. J Control Release 2001, 72:57-70.
40. Tripet B., Wagschal K., Lavigne P., Mant C.T., Hodges R.S. Effects of side-chain characteristics on stability and oligomerization state of a de novo-designed model coiled-coil: 20 amino acid substitutions in position "d". J Mol Biol 2000, 300:377-402.
41. Vandermeulen G.W.M., Tziatzios C., Klok H.A. Reversible self-organization of poly(ethylene glycol)-based hybrid block copolymers mediated by a de novo four-stranded α-helical coiled coil motif. Macromolecules 2003, 36:4107-4114.
42. Vandermeulen G.W.M., Hinderberger D., Xu H., Sheiko S.S., Jeschke G., Klok H.A. Structure and dynamics of self-assembled poly(ethylene glycol) based coiled-coil nano objects. Chemphyschem 2004, 5:488-494.
43. Vandermeulen G.W.M., Tziatzios C., Duncan R., Klok H.A. PEG-based hybrid block copolymers containing α-helical coiled coil peptide sequences: control of self-assembly and preliminary biological evaluation. Macromolecules 2005, 38:761-769.
44. Wagschal K., Tripet B., Hodges R.S. De novo design of a model peptide sequence to examine the effects of single amino acid substitutions in the hydrophobic core on both stability and oligomerization state of coiled-coils. J Mol Biol 1999, 285:785-803.
45. Wang C., Stewart R.J., Kopeček J. Hybrid hydrogels assembled from synthetic polymers and coiled-coil protein domains. Nature 1999, 397:417-420.
46. Wang C., Kopecek J., Stewart R.J. Hybrid hydrogels cross-linked by genetically engineered coiled-coil block proteins. Biomacromolecules 2001, 2:912-920.
47. Wu K.S., Liu J.H., Johnson R.N., Yang J.Y., Kopecek J. Drug-free macromolecular therapeutics: induction of apoptosis by coiled-coil-mediated cross-linking of antigens on the cell surface. Angew Chem Int Edit 2010, 49:1451-1455.
48. Xu T., Shu J. Coiled-coil helix bundle, a peptide tertiary structural motif toward hybrid functional materials. Soft Matter 2010, 6:212-217.
49. Xu C.Y., Breedveld V., Kopecek J. Reversible hydrogels from self-assembling genetically engineered protein block copolymers. Biomacromolecules 2005, 6:1739-1749.
50. Yang J.Y., Xu C.Y., Kopeckova P., Kopecek J. Hybrid hydrogels self-assembled from HPMA copolymers containing peptide grafts. Macromol Biosci 2006, 6:201-209.
51. Yang J.Y., Xu C.Y., Wang C., Kopecek J. Refolding hydrogels self-assembled from N-(2-hydroxypropyl)methacrylamide graft copolymers by antiparallel coiled-coil formation. Biomacromolecules 2006, 7:1187-1195.
52. Yu Y.B. Coiled-coils: stability, specificity, and drug delivery potential. Adv Drug Del Rev 2002, 54:1113-1129.
53. Zavada J., Zavadova Z., Pastorek J., Biesova Z., Jezek J., Velek J. Human tumour-associated cell adhesion protein MN/CA IX: identification of M75 epitope and of the region mediating cell adhesion. Br J Cancer 2000, 82:1808-1813.
54. Zhou N.E., Kay C.M., Hodges R.S. The net energetic contribution of interhelical electrostatic attractions to coiled-coil stability. Protein Eng 1994, 7:1365-1372.